RCM Technologies, Inc. (RCMT)
NASDAQ: RCMT · Real-Time Price · USD
27.55
+0.05 (0.18%)
Jul 23, 2026, 4:00 PM EDT - Market closed
RCM Technologies Financials Overview
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 317.97 | 319.4 | 278.38 | 263.24 | 284.68 | 203.88 |
Revenue Growth | 9.30% | 14.74% | 5.75% | -7.53% | 39.63% | 35.55% |
Gross Profit Gross Profit Growth | 317.97 | 87.94 | 79.78 | 263.24 | 284.68 | 203.88 |
Operating Income Operating Income Growth | 301.89 | 25.09 | 22.33 | 263.24 | 284.68 | 203.88 |
Net Income Net Income Growth | 6.04 | 16.33 | 13.33 | 16.83 | 20.89 | 10.99 |
Earnings Per Share EPS Growth | 2.12 | 2.14 | 1.68 | 1.96 | 2.00 | 0.95 |
EPS Growth | 22.54% | 27.38% | -14.29% | -2.00% | 110.53% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Life Sciences, Data & Solutions Life Sciences, Data & Solutions Growth | 34.56 | 34.81 | 39.24 | 42.32 | 39.3 | 39.21 |
Engineering Engineering Growth | 114.48 | 120.49 | 96.46 | 84.68 | 85.94 | 66.17 |
Specialty Health Care Specialty Health Care Growth | 168.93 | 164.1 | 142.68 | 136.24 | 159.45 | 98.5 |
Total Total Growth | 317.97 | 319.4 | 278.38 | 263.24 | 284.68 | 203.88 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2.62 | 2.92 | 4.73 | 6.28 | 0.34 | 0.24 |
Total Debt Total Debt Growth | 34.54 | 30.92 | 42.18 | 34 | 13.76 | 18.22 |
Net Cash (Debt) Net Cash Growth | -31.92 | -28 | -37.45 | -27.71 | -13.42 | -17.99 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.23 | -3.67 | -4.72 | -3.23 | -1.29 | -1.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 4.98 | 18.97 | 6.17 | 12.48 | 28.28 | 0.92 |
Capital Expenditures CapEx Growth | -1.27 | -1.6 | -2.57 | -2.93 | -0.89 | -0.57 |
Free Cash Flow Free Cash Flow Growth | 3.71 | 17.37 | 3.6 | 9.55 | 27.39 | 0.35 |
Free Cash Flow Growth | -73.64% | 382.77% | -62.33% | -65.14% | 7794.52% | -98.60% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 100.00% | 27.53% | 28.66% | 100.00% | 100.00% | 100.00% |
Operating Margin | 94.94% | 7.86% | 8.02% | 100.00% | 100.00% | 100.00% |
Pretax Margin | 2.83% | 6.91% | 7.25% | 8.43% | 10.00% | 6.82% |
Profit Margin | 1.90% | 5.11% | 4.79% | 6.39% | 7.34% | 5.39% |
FCF Margin | 1.17% | 5.44% | 1.29% | 3.63% | 9.62% | 0.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 24, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 12.99 | 9.28 | 13.79 | 14.82 | 6.17 | 7.49 |
Forward PE | 9.68 | 7.98 | 8.86 | 12.91 | 5.99 | 15.82 |
P/FCF Ratio | 52.63 | 8.41 | 48.96 | 23.85 | 4.18 | 211.16 |
PS Ratio | 0.61 | 0.46 | 0.63 | 0.87 | 0.40 | 0.36 |